This study’s strength is that, to our knowledge, it is the first to evaluate the relationship between BB- DNA, plasma BDNF levels, peripheral inflammatory status, and the progression of cognitive decline in MCI and AD patients. Here, BDNF is linked to Alzheimer disease.